Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193805-20-001272
Filing Date
2020-10-13
Accepted
2020-10-13 16:15:18
Documents
6
Period of Report
2020-11-10
Effectiveness Date
2020-10-13

Document Format Files

Seq Description Document Type Size
1 e619993_def14a-arct.htm DEF 14A 136502
2 GRAPHIC logo.jpg GRAPHIC 6179
3 GRAPHIC image001.jpg GRAPHIC 1161
4 GRAPHIC image002.jpg GRAPHIC 1252
5 GRAPHIC image003.jpg GRAPHIC 953
6 GRAPHIC image004.jpg GRAPHIC 1109
  Complete submission text file 0001193805-20-001272.txt   152937
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38942 | Film No.: 201236425
SIC: 2834 Pharmaceutical Preparations